Petros pharmaceuticals announces first quarter financial results and provides corporate update; reports 300% increase in year-over-year stendra net sales

New york, may 17, 2021 /prnewswire/ -- petros pharmaceuticals, inc. (petros or the company) (nasdaq: ptpi), a leading provider of therapeutics for men's health, today announced financial results for the first quarter ended march 31, 2021. first quarter highlights: 300% increase in stendra® net sales during the first quarter of 2021 vs.
PTPI Ratings Summary
PTPI Quant Ranking